Free Trial

Rocket Pharmaceuticals (RCKT) Insider Trading & Ownership

Rocket Pharmaceuticals logo
$3.40 -0.20 (-5.56%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$3.34 -0.06 (-1.76%)
As of 04:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rocket Pharmaceuticals (NASDAQ:RCKT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
21.30%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$34.10K
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$416.17K
Get RCKT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rocket Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RCKT Insider Buying and Selling by Quarter

Rocket Pharmaceuticals Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/13/2026Sell2,728$3.61$9,848.08  
5/13/2026Sell855$3.61$3,086.55  
5/13/2026
Martin Wilson
Martin Wilson
General Counsel
Sell3,361$3.61$12,133.21  
5/7/2026Sell17,650$3.84$67,776.00  
2/18/2026Sell1,157$3.34$3,864.38  
2/13/2026Sell12,279$3.31$40,643.49  
2/13/2026Sell3,726$3.31$12,333.06  
2/13/2026
Martin Wilson
Martin Wilson
General Counsel
Sell12,253$3.31$40,557.43  
10/14/2025Sell28,918$3.96$114,515.28  
8/27/2025Buy10,000$3.41$34,100.00  
8/19/2025Sell361$3.00$1,083.00  
8/19/2025Sell805$3.00$2,415.00  
8/19/2025
Martin Wilson
Martin Wilson
General Counsel
Sell588$3.00$1,764.00  
8/18/2025Sell699$3.06$2,138.94  
8/18/2025Sell1,680$3.06$5,140.80  
8/18/2025
Martin Wilson
Martin Wilson
General Counsel
Sell1,004$3.06$3,072.24  
8/14/2025Sell7,043$3.02$21,269.86  
8/14/2025Sell11,161$3.02$33,706.22  
8/14/2025
Martin Wilson
Martin Wilson
General Counsel
Sell12,109$3.02$36,569.18  
7/3/2025Sell1,477$2.88$4,253.76  
(Data available from 1/1/2013 forward)

RCKT Insider Trading Activity - Frequently Asked Questions

21.30% of Rocket Pharmaceuticals stock is owned by insiders. Learn more on RCKT's insider holdings.

The following insiders have purchased RCKT shares in the last 24 months: Elisabeth Bjork ($34,100.00), Gaurav Shah ($101,600.00), and Kinnari Patel ($99,165.30).

Insiders have purchased a total of 51,099 RCKT shares in the last 24 months for a total of $234,865.30 bought.

The following insiders have sold RCKT shares in the last 24 months: Aaron Ondrey ($43,870.57), Gaurav Shah ($423,825.62), John Militello ($232,592.52), Jonathan David Schwartz ($41,262.02), Mark Andrew White ($61,700.14), Martin Wilson ($133,900.61), and Sarbani Chaudhuri ($67,776.00).

Insiders have sold a total of 158,202 Rocket Pharmaceuticals shares in the last 24 months for a total of $1,004,927.48 sold.



This page (NASDAQ:RCKT) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners